Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01826864
What this trial is testing

Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma

Who this might be right for
Stage IB MelanomaStage IIA MelanomaStage IIB Melanoma+1 more
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT06621810
What this trial is testing

Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children, Adolescents and Young Adults

Who this might be right for
Melanoma (Skin Cancer)Artificial Intelligence (AI)Pediatric Cancer
German Cancer Research Center 3,000
Not applicableActive Not RecruitingNCT04611568
What this trial is testing

War on Melanoma™ Public Health & Education Campaign

Who this might be right for
Melanoma
OHSU Knight Cancer Institute 75,000
Not applicableActive Not RecruitingNCT06246227
What this trial is testing

CtDNA for Early Detection of Recurrence in Melanoma

Who this might be right for
Melanoma
Herlev and Gentofte Hospital 467
Not applicableStudy completedNCT06613230
What this trial is testing

Improved Early Diagnosis in Female Pelvic Cancer With OC Detect

Who this might be right for
Ovarian CancerEndometrial CancerBreast Cancer+3 more
Region Skane 490
Not applicableLooking for participantsNCT04354064
What this trial is testing

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Who this might be right for
Healthy VolunteerProstate CancerHead and Neck Cancer+10 more
Washington University School of Medicine 100
Not applicableStudy completedNCT03584334
What this trial is testing

18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma

Who this might be right for
Non-Small Cell Bronchopulmonary Carcinoma or Melanoma
Centre Antoine Lacassagne 100
Not applicableStudy completedNCT03057327
What this trial is testing

Promoting Early Detection of Melanoma During the Mammography Experience

Who this might be right for
Melanoma (Skin Cancer)
Northwestern University 560
Not applicableWithdrawnNCT03205722
What this trial is testing

The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany

Who this might be right for
Melanoma
Bristol-Myers Squibb
Not applicableLooking for participantsNCT06488365
What this trial is testing

In Vivo Liquid Biopsy of Melanoma (Cytophone)

Who this might be right for
MelanomaCirculating Tumor CellsMetastatic Melanoma+1 more
Cytoastra 180
Not applicableActive Not RecruitingNCT05015816
What this trial is testing

MoleGazer Development Feasibility Study

Who this might be right for
Melanoma (Skin)Moles Multiple Benign
Oxford University Hospitals NHS Trust 374
Not applicableStudy completedNCT00351728
What this trial is testing

Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Who this might be right for
Ocular MelanomaChoroidal MelanomaUveal Melanoma
Jonsson Comprehensive Cancer Center 174
Not applicableEnrolling By InvitationNCT07328516
What this trial is testing

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Who this might be right for
Prostate CancerLeukemiaBreast Cancer+2 more
National Cancer Institute (NCI) 64,277
Not applicableStudy completedNCT03693378
What this trial is testing

IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups

Who this might be right for
Pancreatic Ductal AdenocarcinomaFamilial Pancreatic CancerFAMMM - Familial Atypical Mole Malignant Melanoma Syndrome
Immunovia, Inc. 1,349
Not applicableEnded earlyNCT00776945
What this trial is testing

Feasibility and Functionality of fPAM Imaging in Melanoma

Who this might be right for
Melanoma
Washington University School of Medicine 2
Not applicableUnknownNCT06281912
What this trial is testing

Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients

Who this might be right for
Early MelanomaAdvanced Melanoma
Azienda Ospedaliera di Perugia 70
Not applicableStudy completedNCT04680182
What this trial is testing

Early Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma Patients

Who this might be right for
MelanomaComplication
Oslo University Hospital 104
Not applicableUnknownNCT03132090
What this trial is testing

Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI

Who this might be right for
Malignant Melanoma Stage IV
University Hospital Tuebingen 106
Not applicableStudy completedNCT06221397
What this trial is testing

AI-based Medical Device Validation for Early Melanoma Detection

Who this might be right for
MelanomaMelanoma, Skin
AI Labs Group S.L 105
Not applicableAvailableNCT06751524
What this trial is testing

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Who this might be right for
Colorectal Cancer (CRC)Pancreatic CancerNon-Small Cell Lung Cancer (NSCLC)+5 more
Agenus Inc.
Next Page